Using ultrasound to diagnose pleural diseases
An Open Labeled Clinical Trial of Medical Device, for Diagnosis and Classification of Pleural Diseases Using Ultrasound Channel Data, While Minimizing Sampling Rate and Data Volume
This study is testing if using ultrasound can help doctors better diagnose and understand pleural diseases like pneumothorax and pleural effusion in patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | HaEmek Medical Center, Israel Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Afula) |
| Trial ID | NCT04418804 on ClinicalTrials.gov |
What this trial studies
This study focuses on the use of ultrasound imaging to diagnose and classify pleural diseases such as pneumothorax and pleural effusion. It aims to improve diagnostic accuracy by utilizing advanced ultrasound channel data, which can provide detailed insights into the pleura's condition. Participants will undergo chest ultrasound scans to assess their pleural health, with a focus on those diagnosed with these conditions within specific time frames. The study seeks to enhance the understanding and management of pleural diseases through innovative imaging techniques.
Who should consider this trial
Good fit: Ideal candidates include healthy volunteers and those with active pneumothorax or pleural effusion confirmed by prior imaging.
Not a fit: Patients whose conditions were not detected during the actual ultrasound exam may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and timely diagnoses of pleural diseases, improving patient outcomes.
How similar studies have performed: Other studies have shown promise in using ultrasound for diagnosing pleural conditions, indicating that this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy volunteers * Volunteers with active Pneumothorax, detected by prior imaging studies up to 24 hours before the ultrasound scan * Volunteers with active Pleural effusion, detected by prior imaging studies up to 48 hours before the ultrasound scan ult Exclusion Criteria: * Volunteers with the aforementioned diagnosis, which was not detected during the actual ultrasound exam * Volunteers who expressed their desire to be excluded from the study at any given time point.
Where this trial is running
Afula
- Emek medical center — Afula, Israel (Recruiting)
Study contacts
- Principal investigator: Israel Israel, M.D. Ph.D — Imaging institute, Haemek Medical Center, Afula, Israel.
- Study coordinator: Israel Aharony, M.D. Ph.D
- Email: elik.aharony@gmail.com
- Phone: 97246495635
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.